J Finsterer, C Stöllberger. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAdultAnalgesics, Opioid/therapeutic useBulbo-Spinal Atrophy, X-Linked/complicationsBulbo-Spinal Atrophy, X-Linked/physiopathologyDisease ProgressionDysarthria/geneticsDysarthria/physiopathologyFasciculation/geneticsFasciculation/physiopathologyHumansInheritance Patterns/physiologyMaleMuscle Cramp/drug therapyMuscle Cramp/etiologyMuscle Cramp/physiopathologyMuscle Relaxants, Central/administration & dosageMuscle Weakness/geneticsMuscle Weakness/physiopathologyMuscle, Skeletal/drug effectsMuscle, Skeletal/pathologyMuscle, Skeletal/physiopathologyPain/drug therapyPain/geneticsPain/physiopathologyQuinine/administration & dosageRespiratory Paralysis/geneticsRespiratory Paralysis/physiopathologyTreatment OutcomeTremor/geneticsTremor/physiopathology
Substances: See more » Adrenergic beta-AntagonistsAnalgesics, OpioidMuscle Relaxants, CentralQuinine
Year: 2009 PMID: 19306034 DOI: 10.1007/s00415-009-5101-y
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849